Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis. // Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S240557942600029X?dgcid=rss_sd_all
Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. https://www.sciencedirect.com/science/article/pii/S240557942600029X?dgcid=rss_sd_all
“Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis.” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.
@article{article53132,
title = {Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis},
journal = {Journal of Clinical Tuberculosis and Other Mycobacterial Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S240557942600029X?dgcid=rss_sd_all}
}